Login with your work email address to view charts. No credit card required.
| Art Unit: | 1691 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1690 — Organometallics & Industrial Chemistry and Carbohydrate Chemistry |
| Classes: |
514 — Drug, bio-affecting and body treating compositions 345 — Computer graphics processing and selective visual display systems 424 — Drug, bio-affecting and body treating compositions 426 — Food or edible material: processes, compositions, and products 436 — Chemistry: analytical and immunological testing 435 — Chemistry: molecular biology and microbiology 178 — Telegraphy |
| Phone: | (571) 270-1016 |
| Email: | andrew.lee1@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr Cheml Engrg |
| Service: | 14 years |
| Grade: | GS-13 |
| 3-Year Grant rate: | 49% over 431 cases |
|---|---|
| Difficulty: | Very Hard |
| Difficulty Percentile: | 81st
|
With Examiner Lee, you have a 49% chance of getting an issued patent by 3 years after the first office action. Examiner Lee is a very hard examiner and in the 81st percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Lee, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Lee's grant rate is lower than that of Art Unit 1691 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Lee | 2.3 |
| Art Unit 1691 | 1.1 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.